New Market Research Report: South Africa Pharmaceuticals & Healthcare Report Q2 2013
The Ministry of Health announced this quarter it would increase 2013 drug manufacturing prices by a maximum of 5.8% in the private sector. This is below expectations, and in addition to the continued depreciation of the Rand, should be seen as an opportunity for local drugmakers to shift focus towards increasing exports to emerging markets in order to drive long-term revenues. Although the government favours local drugmakers in tender allocations, increasing generic drug competition and downward pressure on drug prices,...
View full press release